P01.029 Open-label phase 1 clinical trial testing personalized and targeted skull remodeling surgery to maximize TTFields intensity for recurrent glioblastoma - Interim analysis and safety assessment (OptimalTTF-1)

BACKGROUND: We present a pre-specified interim analysis of an ongoing open-label, investigator-sponsored phase 1 trial (NCT02893137) testing safety/efficacy of a new rGBM treatment. The intervention combines personalized skull-remodeling (SR) surgery with TTFields and best-choice chemotherapy. SR-su...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Autores principales: Korshoej, A R, Lukacova, S, Sørensen, J H, Hansen, F L, Mikic, N, Thielscher, A, Cortnum, S O S, Guldberg, T L, Lassen-Ramshad, Y, Rahbek, C, Severinsen, K E, von Oettingen, G B
Formato: Artigo
Lenguaje:Inglês
Publicado: Oxford University Press 2018
Materias:
Poster Presentations
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144088/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.071
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares